Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19
Of the 62% of participants in a CanPath study who had infection-acquired antibodies, 86% had never suspected they had previously had COVID-19. These results from the CanPath SUPPORT-Canada study “Real-world insights on COVID-19 vaccine effectiveness and risk factors for COVID-19 infection” were made public during a hybrid event on May 30th.